Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007196
Chunk: 129

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 129
---
 statement relating to the securities offered therein, and 
 the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.                            |

| II-4 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant
certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in London, United Kingdom, on this 8th
day of May, 2025.

| BIODEXA PHARMACEUTICALS PLC |                         |
| By:                         | /s/ Stephen Stamp       |
|                             | Stephen Stamp           |
|                             | Chief Executive Officer |

Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement on Form F-1 has been signed by the following persons in the capacities and on the
date indicated.

| Name and Signature    
 /s/ Stephen Stamp     |     | Title(s)                                                                                  
 Chief Executive Officer, Director,                                                        |     | Date        
 May 8, 2025 |
|:----------------------|:----|:------------------------------------------------------------------------------------------|:----|:------------|
| Stephen Stamp         |     | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |             |
| *                     |     | Non-Executive Chairman of the Board                                                       |     | May 8, 2025 |
| Stephen Parker        |     |                                                                                           |     |             |
| *                     |     | Senior Independent Non-Executive Director                                                 |     | May 8, 2025 |
| Simon Turton, Ph.D.   |     |                                                                                           |     |             |
| *                     |     | Non-Executive Director                                                                    |     | May 8, 2025 |
| Sijmen de Vries, M.D. |     |                                                                                           |     |             |
| *                     |     | Non-Executive Director                                                                    |     | May 8, 2025 |
| Ann Merchant          |     |                                                                                           |     |             |

| *By: | /s/ Stephen Stamp |
|      | Stephen Stamp     |
|      | Attorney-in-fact  |

| II-5 |

<div align='center'>AUTHORIZED REPRESENTATIVE</div>

Pursuant to the requirements